On March 30, 2022, Mr. Noel Spiegel, who has served as a director and Chair of the Audit Committee of the Board of vTv Therapeutics Inc. since its initial public offering in 2015, notified the Company of his decision not to stand for re-election at the Company's 2022 annual meeting of stockholders. Mr. Spiegel's decision not to stand for re-election was not because of a disagreement on any matter relating to the Company's operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.01 USD | 0.00% | +12.09% | +152.26% |
09/05 | VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/03 | VTv Therapeutics Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+152.26% | 70.58M | |
+10.27% | 115B | |
+11.57% | 106B | |
-5.97% | 24.69B | |
-1.60% | 21.97B | |
-5.20% | 19.27B | |
-11.10% | 17.56B | |
-39.36% | 17.32B | |
+5.44% | 14.03B | |
+32.93% | 12.13B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- VTv Therapeutics Inc. Announces Not to Stand for Re-Election of Noel Spiegel as Director and Chair of the Audit Committee of the Board